SEARCH

SEARCH BY CITATION

References

  • Accardi A. and Miller C. (2004) Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels. Nature 427, 803807.
  • Amara S. G. and Kuhar M. J. (1993) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 7393.
  • Axelrod J., Whitby L. G. and Hertting G. (1961) Effect of psychotropic drugs on the uptake of 3H-Norepinephrine by tissues. Science 133, 383384.
  • Barger G. and Dale H. H. (1910) Chemical structure and sympathomimetic action of amines. J. Physiol. 41, 1959.
  • Berfield J. L., Wang L. C. and Reith M. E. (1999) Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species? J. Biol. Chem. 274, 48764882.
  • Binda F., Dipace C., Bowton E. et al. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 11011108.
  • Bonisch H. (1984) The transport of (+)-amphetamine by the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch. Pharmacol. 327, 267272.
  • Bönisch H. (1986) The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn Schmiedebergs Arch. Pharmacol. 332, 135141.
  • Bönisch H. and Trendelenburg U. (1989) The mechanism of action of indirectly acting sympathomimetic amines, in Handbook of Experimental Pharmacology: Catecholamines (TrendelenburgU. and WeinerN., eds), pp. 247277. Springer, Berlin, Hamburg, New York.
  • Bruns D., Engert F. and Lux H.-D. (1993) A fast activating presynaptic reuptake current during serotonergic transmisson in identified neurons of Hirudo. Neuron 10, 559572.
  • Bruss M., Hammermann R., Brimijoin S. and Bonisch H. (1995) Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J. Biol. Chem. 270, 91979201.
  • Burn J. H. and Rand M. J. (1958) The action of sympathomimetic amines in animals treated with reserpine. J. Physiol. 144, 314336.
  • Carvelli L., McDonald P. W., Blakely R. D. and DeFelice L. J. (2004) Dopamine transporters depolarize neurons by a channel mechanism. Proc. Natl Acad. Sci. USA 101, 1604616051.
  • Chaudhry F. A., Boulland J. L., Jenstad M., Bredahl M. K. and Edwards R. H. (2008) Pharmacology of neurotransmitter transport into secretory vesicles. Handb. Exp. Pharmacol. 184, 77106.
  • Chen N. and Reith M. E. (2000) Structure and function of the dopamine transporter. Eur. J. Pharmacol. 405, 329339.
  • Chen R., Furman C. A., Zhang M., Kim M. N., Gereau R. W., Leitges M. and Gnegy M. E. (2009) Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J. Pharmacol. Exp. Ther. 328, 912920.
  • Chi L. and Reith M. E. (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J. Pharmacol. Exp. Ther. 307, 729736.
  • Cinquanta M., Ratovitski T., Crespi D., Gobbi M., Mennini T. and Simantov R. (1997) Carrier-mediated serotonin release induced by d-fenfluramine: studies with human neuroblastoma cells transfected with a rat serotonin transporter. Neuropharmacology 36, 803809.
  • Davis M. E. and Patrick R. L. (1990) Diacylglycerol-induced stimulation of neurotransmitter release from rat brain striatal synaptosomes. J. Neurochem. 54, 662668.
  • Diez-Sampedro A., Hirayama B. A., Osswald C., Gorboulev V., Baumgarten K., Volk C., Wright E. M. and Koepsell H. (2003) A glucose sensor hiding in a family of transporters. Proc. Natl Acad. Sci. USA 100, 1175311758.
  • Dipace C., Sung U., Binda F., Blakely R. D. and Galli A. (2007) Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol. Pharmacol. 71, 230239.
  • Egana L. A., Cuevas R. A., Baust T. B. et al. (2009) Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J. Neurosci. 29, 45924604.
  • Eriksen J., Rasmussen S. G., Rasmussen T. N., Vaegter C. B., Cha J. H., Zou M. F., Newman A. H. and Gether U. (2009) Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J. Neurosci. 29, 67946808.
  • Erreger K., Grewer C., Javitch J. A. and Galli A. (2008) Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J. Neurosci. 28, 976989.
  • Eshleman A. J., Henningsen R. A., Neve K. A. and Janowsky A. (1994) Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312316.
  • Ewing A. G., Stein T. S. and Lau Y. Y. (1992) Analytical chemistry in microenvironments: single nerve cells. Accts. Chem. Res. 25, 440447.
  • Falkenburger B. H., Barstow K. L. and Mintz I. M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science 293, 24652470.
  • Farhan H., Korkhov V. M., Paulitschke V., Dorostkar M. M., Scholze P., Kudlacek O., Freissmuth M. and Sitte H. H. (2004) Two discontinuous segments in the carboxy terminus are required for membrane targeting of the rat GABA transporter-1 (GAT1). J. Biol. Chem. 279, 2855328563.
  • Farhan H., Freissmuth M. and Sitte H. H. (2006) Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. Handb. Exp. Pharmacol. 175, 233249.
  • Farhan H., Reiterer V., Korkhov V. M., Schmid J. A., Freissmuth M. and Sitte H. H. (2007) Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J. Biol. Chem. 282, 76797689.
  • Farhan H., Reiterer V., Kriz A., Hauri H. P., Pavelka M., Sitte H. H. and Freissmuth M. (2008) Signal-dependent export of GABA transporter 1 from the ER-Golgi intermediate compartment is specified by a C-terminal motif. J. Cell Sci. 121, 753761.
  • Fischer J. F. and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208, 203209.
  • Fishkes H. and Rudnick G. (1982) Bioenergetics of serotonin transport by membrane vesicles derived from platelet dense granules. J. Biol. Chem. 257, 56715677.
  • Fjorback A. W., Pla P., Muller H. K., Wiborg O., Saudou F. and Nyengaard J. R. (2009) Serotonin transporter oligomerization documented in RN46A cells and neurons by sensitized acceptor emission FRET and fluorescence lifetime imaging microscopy. Biochem. Biophys. Res. Commun. 380, 724728.
  • Fleckenstein A. and Burn J. H. (1953) The effect of denervation on the action of sympathomimetic amines on the nictitating membrane. Br. J Pharmacol. Chemother. 8, 6978.
  • Fog J. U., Khoshbouei H., Holy M. et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417429.
  • Fon E. A., Pothos E. N., Sun B. C., Killeen N., Sulzer D. and Edwards R. H. (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19, 12711283.
  • Forrest L. R., Zhang Y. W., Jacobs M. T., Gesmonde J., Xie L., Honig B. H. and Rudnick G. (2008) Mechanism for alternating access in neurotransmitter transporters. Proc. Natl Acad. Sci. USA 105, 1033810343.
  • Foster J. D., Pananusorn B. and Vaughan R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 2517825186.
  • Foster J. D., Cervinski M. A., Gorentla B. K. and Vaughan R. A. (2006) Regulation of the dopamine transporter by phosphorylation. Handb. Exp. Pharmacol. 175, 197214.
  • Fröhlich A. and Loewi O. (1910) Über eine Steigerung der Adrenalinempfindlichkeit durch Cocain. (On the increase in the adrenalin sensitivity induced by cocaine). Arch. exp. Pathol. Pharmakol. 62, 159169.
  • Furchgott R. F., Kirpekar S. M., Rieker M. and Schwab A. (1963) Actions and interactions of norepinephrine, tyramine and cocaine on aortic strips of rabbit and left atria of guinea pig and cat. J. Pharmacol. Exp. Ther. 142, 3958.
  • Galli A., DeFelice L. J., Duke B. J., Moore K. R. and Blakely R. D. (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198, 21972212.
  • Galli A., Petersen C. I., DeBlaquiere M., Blakely R. D. and DeFelice L. J. (1997) Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. J. Neurosci. 17, 34013411.
  • Galli A., Blakely R. D. and DeFelice L. J. (1998) Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. Proc. Natl Acad. Sci. USA 95, 1326013265.
  • Giambalvo C. T. (1992a) Protein kinase C and dopamine transport–1. Effects of amphetamine in vivo. Neuropharmacology 31, 12011210.
  • Giambalvo C. T. (1992b) Protein kinase C and dopamine transport—2. Effects of amphetamine in vitro. Neuropharmacology 31, 12111222.
  • Giambalvo C. T. (2003) Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Synapse 49, 125133.
  • Glowinski J. and Axelrod J. (1965) Effect of drugs on the uptake, release, and metabolism of H3-norepinephrine in the rat brain. J. Pharmacol. Exp. Ther. 149, 4349.
  • Gnegy M. E. (2003) The effect of phosphorylation on amphetamine-mediated outward transport. Eur. J. Pharmacol. 479, 8391.
  • Gnegy M. E., Khoshbouei H., Berg K. A., Javitch J. A., Clarke W. P., Zhang M. and Galli A. (2004) Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Mol. Pharmacol. 66, 137143.
  • Gobbi M., Mennini T. and Garattini S. (1997) Mechanism of neurotransmitter release induced by amphetamine derivatives: pharmacological and toxicological aspects. Curr. Top. Pharmacol. 3, 217227.
  • Gobbi M., Moia M., Pirona L., Ceglia I., Reyes-Parada M., Scorza C. and Mennini T. (2002) p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. J. Neurochem. 82, 14351443.
  • Gobbi M., Funicello M., Gerstbrein K. et al. (2008) N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. J. Neurochem. 105, 17701780.
  • Gorentla B. K., Moritz A. E., Foster J. D. and Vaughan R. A. (2009) Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry 48, 10671076.
  • Granas C., Ferrer J., Loland C. J., Javitch J. A. and Gether U. (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 49905000.
  • Green A. R., Mechan A. O., Elliott J. M., O’Shea E. and Colado M. I. (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol. Rev. 55, 463508.
  • Hansra N., Arya S. and Quick M. W. (2004) Intracellular domains of a rat brain GABA transporter that govern transport. J. Neurosci. 24, 40824087.
  • Hastrup H., Karlin A. and Javitch J. A. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross- linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl Acad. Sci. USA 98, 1005510060.
  • Hilgemann D. W. and Lu C. C. (1999) GAT1 (GABA:Na+:Cl−) cotransport function. Database reconstruction with an alternating access model. J. Gen. Physiol. 114, 459475.
  • Hoover B. R., Everett C. V., Sorkin A. and Zahniser N. R. (2007) Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations. J. Neurochem. 101, 12581271.
  • Humphreys C. J., Wall S. C. and Rudnick G. (1994) Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence. Biochemistry 33, 91189125.
  • Ingram S. L., Prasad B. M. and Amara S. G. (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5, 971978.
  • Iversen L. L. (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 41, 571591.
  • Iversen L. (2000) Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol. Psychiatry 5, 357362.
  • Jardetzky O. (1966) Simple allosteric model for membrane pumps. Nature 211, 969970.
  • Javitch J. A., D’Amato R. J., Strittmatter S. M. and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl Acad. Sci. USA 82, 21732177.
  • Jess U., Betz H. and Schloss P. (1996) The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein. FEBS Lett. 394, 4446.
  • Johnson L. A., Guptaroy B., Lund D., Shamban S. and Gnegy M. E. (2005) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 280, 1091410919.
  • Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 19791986.
  • Jones S. R., Joseph J. D., Barak L. S., Caron M. G. and Wightman R. M. (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73, 24062414.
  • Just H., Sitte H. H., Schmid J. A., Freissmuth M. and Kudlacek O. (2004) Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J. Biol. Chem. 279, 66506657.
  • Kahlig K. M., Binda F., Khoshbouei H., Blakely R. D., McMahon D. G., Javitch J. A. and Galli A. (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Natl Acad. Sci. USA 102, 34953500.
  • Kantor L. and Gnegy M. E. (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284, 592598.
  • Kantor L., Hewlett G. H. and Gnegy M. E. (1999) Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J. Neurosci. 19, 38013808.
  • Kantor L., Hewlett G. H., Park Y. H., Richardson-Burns S. M., Mellon M. J. and Gnegy M. E. (2001) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J. Pharmacol. Exp. Ther. 297, 10161024.
  • Kazanietz M. G., Caloca M. J., Aizman O. and Nowicki S. (2001) Phosphorylation of the catalytic subunit of rat renal Na+, K+-ATPase by classical PKC isoforms. Arch. Biochem. Biophys. 388, 7480.
  • Khoshbouei H., Wang H., Lechleiter J. D., Javitch J. A. and Galli A. (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J. Biol. Chem. 278, 1207012077.
  • Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M. E., Galli A. and Javitch J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78.
  • Kilic F. and Rudnick G. (2000) Oligomerization of serotonin tranporter and its functional consequences. Proc. Natl Acad. Sci. USA 97, 31063111.
  • Kocabas A. M., Rudnick G. and Kilic F. (2003) Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85, 15131520.
  • Korkhov V. M., Holy M., Freissmuth M. and Sitte H. H. (2006) The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle. J. Biol. Chem. 281, 1343913448.
  • L’hirondel M., Cheramy A., Godeheu G. and Glowinski J. (1995) Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J. Neurochem. 64, 14061409.
  • Langeloh A. and Trendelenburg U. (1987) The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline. Naunyn Schmiedebergs Arch. Pharmacol. 336, 611620.
  • Langston J. W., Irwin I., Langston E. B. and Forno L. S. (1984) 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48, 8792.
  • Lester H. A., Cao Y. and Mager S. (1996) Listening to neurotransmitter transporters. Neuron 17, 807810.
  • Levi G. and Raiteri M. (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci. 16, 415419.
  • Liu Y., Peter D., Roghani A., Schuldiner S., Prive G. G., Eisenberg D., Brecha N. and Edwards R. H. (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70, 539551.
  • Liu Y., Vidensky S., Ruggiero A. M., Maier S., Sitte H. H. and Rothstein J. D. (2008) Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J. Biol. Chem. 283, 65616571.
  • Loland C. J., Norregaard L. and Gether U. (1999) Defining proximity relationships in the tertiary structure of the dopamine transporter. Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn(2+)-binding site. J. Biol. Chem. 274, 3692836934.
  • Lu C. C. and Hilgemann D. W. (1999a) GAT1 (GABA:Na+:Cl−) cotransport function. Kinetic studies in giant Xenopus oocyte membrane patches. J. Gen. Physiol. 114, 445457.
  • Lu C. C. and Hilgemann D. W. (1999b) GAT1 (GABA:Na+:Cl−) cotransport function. Steady state studies in giant Xenopus oocyte membrane patches. J. Gen. Physiol. 114, 429444.
  • Mager S., Min C., Henry D. J., Chavkin C., Hoffman B. J., Davidson N. and Lester H. A. (1994) Conducting states of a mammalian serotonin transporter. Neuron 12, 845859.
  • Mager S., Kleinberger D. N., Keshet G. I., Davidson N., Kanner B. I. and Lester H. A. (1996) Ion binding and permeation at the GABA transporter GAT1. J. Neurosci. 16, 54055414.
  • Maier S., Reiterer V., Ruggiero A. M., Rothstein J. D., Thomas S., Dahm R., Sitte H. H. and Farhan H. (2009) GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation. J. Cell Mol. Med. 13, 114124.
  • Masson J., Sagne C., Hamon M. and El Mestikawy S. (1999) Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439464.
  • Mazei-Robinson M. S. and Blakely R. D. (2006) ADHD and the dopamine transporter: are there reasons to pay attention? Handb. Exp. Pharmacol. 175, 373415.
  • Mazei-Robison M. S., Bowton E., Holy M., Schmudermaier M., Freissmuth M., Sitte H. H., Galli A. and Blakely R. D. (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J. Neurosci. 28, 70407046.
  • Meinild A. K., Sitte H. H. and Gether U. (2004) Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J. Biol. Chem. 279, 4967149679.
  • Moron J. A., Zakharova I., Ferrer J. V. et al. (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J. Neurosci. 23, 84808488.
  • Mosharov E. V., Gong L. W., Khanna B., Sulzer D. and Lindau M. (2003) Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells. J. Neurosci. 23, 58355845.
  • Mosharov E. V., Larsen K. E., Kanter E., Phillips K. A., Wilson K., Schmitz Y., Krantz D. E., Kobayashi K., Edwards R. H. and Sulzer D. (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62, 218229.
  • Nelson N. (1998) The family of Na+/Cl− neurotransmitter transporters. J. Neurochem. 71, 17851803.
  • Nirenberg M. J., Chan J., Vaughan R. A., Uhl G. R., Kuhar M. J. and Pickel V. M. (1997) Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J. Neurosci. 17, 52555262.
  • Norregaard L., Frederiksen D., Nielsen E. O. and Gether U. (1998) Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J. 17, 42664273.
  • Petersen C. I. and DeFelice L. J. (1999) Ionic interactions in the Drosophila serotonin transporter identify it as a serotonin channel. Nat. Neurosci. 2, 605610.
  • Pettersen E. F., Goddard T. D., Huang C. C., Couch G. S., Greenblatt D. M., Meng E. C. and Ferrin T. E. (2004) UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 16051612.
  • Pifl C. and Singer E. A. (1999) Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 56, 10471054.
  • Pifl C., Drobny H., Reither H., Hornykiewicz O. and Singer E. A. (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47, 368373.
  • Pifl C., Agneter E., Drobny H., Reither H. and Singer E. A. (1997) Induction by low Na+ or Cl− of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters. Br. J. Pharmacol. 121, 205212.
  • Pifl C., Agneter E., Drobny H., Sitte H. H. and Singer E. A. (1999) Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells. Neuropharmacology 38, 157165.
  • Pifl C., Rebernik P., Kattinger A. and Reither H. (2004) Zn2+ modulates currents generated by the dopamine transporter: parallel effects on amphetamine-induced charge transfer and release. Neuropharmacology 46, 223231.
  • Pifl C., Wolf A., Rebernik P., Reither H. and Berger M. L. (2009) Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner. Neuropharmacology 56, 531540.
  • Pozzan T., Gatti G., Dozio N., Vicentini L. M. and Meldolesi J. (1984) Ca2+-dependent and -independent release of neurotransmitters from PC12 cells: a role for protein kinase C activation? J. Cell Biol. 99, 628638.
  • Quick M. W., Hu J., Wang D. and Zhang H. Y. (2004) Regulation of a gamma-aminobutyric acid transporter by reciprocal tyrosine and serine phosphorylation. J. Biol. Chem. 279, 1596115967.
  • Ramamoorthy S. and Blakely R. D. (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285, 763766.
  • Ramamoorthy S., Samuvel D. J., Buck E. R., Rudnick G. and Jayanthi L. D. (2007) Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP. J. Biol. Chem. 282, 1163911647.
  • Ramsey I. S. and DeFelice L. J. (2002) Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor. J. Biol. Chem. 277, 1447514482.
  • Reiterer V., Maier S., Sitte H. H., Kriz A., Ruegg M. A., Hauri H. P., Freissmuth M. and Farhan H. (2008) Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targeting. J. Neurosci. 28, 1245312464.
  • Ressl S., Terwisscha van Scheltinga A. C., Vonrhein C., Ott V. and Ziegler C. (2009) Molecular basis of transport and regulation in the Na(+)/betaine symporter BetP. Nature 458, 4752.
  • Robertson S. D., Matthies H. J. and Galli A. (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol. Neurobiol. 39, 7380.
  • Robinson J. B. (1985) Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl. Biochem. Pharmacol. 34, 41054108.
  • Ross S. B. and Kelder D. (1977) Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex. Acta Physiol. Scand. 99, 2736.
  • Ross S. B. and Renyi A. L. (1966) Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro. Acta Pharmacol. Toxicol. (Copenh) 24, 297309.
  • Roux M. J. and Supplisson S. (2000) Neuronal and glial glycine transporters have different stoichiometries. Neuron 25, 373383.
  • Rudnick G. (1999) Ion-coupled neurotransmitter transport: thermodynamic vs. kinetic determinations of stoichiometry. Methods Enzymol. 296, 233247.
  • Rudnick G. (2002) Mechanism of biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (ReithM. E. A., ed.), pp. 2552. Humana Press Inc, Totowa, NJ.
  • Rudnick G. and Clark J. (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta 1144, 249263.
  • Rudnick G. and Wall S. C. (1992) p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31, 67106718.
  • Ruggiero A. M., Liu Y., Vidensky S., Maier S., Jung E., Farhan H., Robinson M. B., Sitte H. H. and Rothstein J. D. (2008) The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein. J. Biol. Chem. 283, 61756183.
  • Saier M. H. Jr, Tran C. V. and Barabote R. D. (2006) TCDB: the Transporter Classification Database for membrane transport protein analyses and information. Nucleic Acids Res. 34, D181D186.
  • Scheel O., Zdebik A. A., Lourdel S. and Jentsch T. J. (2005) Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436, 424427.
  • Schmid J. A., Scholze P., Kudlacek O., Freissmuth M., Singer E. A. and Sitte H. H. (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276, 38053810.
  • Scholze P., Zwach J., Kattinger A., Pifl C., Singer E. A. and Sitte H. H. (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter. J. Pharmacol. Exp. Ther. 293, 870878.
  • Scholze P., Freissmuth M. and Sitte H. H. (2002a) Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J. Biol. Chem. 277, 4368243690.
  • Scholze P., Norregaard L., Singer E. A., Freissmuth M., Gether U. and Sitte H. H. (2002b) The role of zinc ions in reverse transport mediated by monoamine transporters. J. Biol. Chem. 277, 2150521513.
  • Schömig A., Fischer S., Kurz T., Richardt G. and Schömig E. (1987) Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ. Res. 60, 194205.
  • Schuldiner S., Steiner M. S., Yelin R., Wall S. C. and Rudnick G. (1993) Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmacol. 44, 12271231.
  • Schuldiner S., Shirvan A. and Linial M. (1995) Vesicular neurotransmitter transporters: from bacteria to humans. Physiol. Rev. 75, 369392.
  • Seidel S., Singer E. A., Just H. et al. (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol. Pharmacol. 67, 140151.
  • Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639677.
  • Sen N., Shi L., Beuming T., Weinstein H. and Javitch J. A. (2005) A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding. Neuropharmacology 49, 780790.
  • Shi L., Quick M., Zhao Y., Weinstein H. and Javitch J. A. (2008) The mechanism of a neurotransmitter:sodium symporter–inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol. Cell 30, 667677.
  • Singh S. K. (2008) LeuT: A prokaryotic stepping stone on the way to a eukaryotic neurotransmitter transporter structure. Channels (Austin.) 2, 380389.
  • Singh S. K., Piscitelli C. L., Yamashita A. and Gouaux E. (2008) A competitive inhibitor traps LeuT in an open-to-out conformation. Science 322, 16551661.
  • Sitte H. H. and Freissmuth M. (2003) Oligomer formation by Na+-Cl−-coupled neurotransmitter transporters. Eur. J. Pharmacol. 479, 229236.
  • Sitte H. H., Huck S., Reither H., Boehm S., Singer E. A. and Pifl C. (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71, 12891297.
  • Sitte H. H., Scholze P., Schloss P., Pifl C. and Singer E. A. (2000) Characterization of carrier-mediated release in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study. J. Neurochem. 74, 13171324.
  • Sitte H. H., Hiptmair B., Zwach J., Pifl C., Singer E. A. and Scholze P. (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 59, 11291137.
  • Sitte H. H., Singer E. A. and Scholze P. (2002) Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1. Br. J. Pharmacol. 135, 93102.
  • Sitte H. H., Farhan H. and Javitch J. A. (2004) Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol. Interv. 4, 3847.
  • Sonders M. S. and Amara S. G. (1996) Channels in transporters. Curr. Opin. Neurobiol. 6, 294302.
  • Sonders M. S., Zhu S. J., Zahniser N. R., Kavanaugh M. P. and Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960974.
  • Sorkina T., Doolen S., Galperin E., Zahniser N. R. and Sorkin A. (2003) Oligomerization of dopamine transporters visualized in living cells by FRET microscopy. J. Biol. Chem. 278, 2827428283.
  • Sorkina T., Miranda M., Dionne K. R., Hoover B. R., Zahniser N. R. and Sorkin A. (2006) RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J. Neurosci. 26, 81958205.
  • Stein W. D. (1967) The Movement of Molecules Across Cell Membranes. Academic Press, New York.
  • Su A., Mager S., Mayo S. L. and Lester H. A. (1996) A multi-substrate single-file model for ion-coupled transporters. Biophys. J. 70, 762777.
  • Sulzer D. and Galli A. (2003) Dopamine transport currents are promoted from curiosity to physiology. Trends Neurosci. 26, 173176.
  • Sulzer D., Maidment N. T. and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527535.
  • Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S. and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 41024108.
  • Sulzer D., Sonders M. S., Poulsen N. W. and Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406433.
  • Tainter M. L. and Chang D. K. (1927) The antagonism of sympathetic and adrenaline content of the spleen, kidney, and salivary glands in the sheep. J. Pharmacol. Exp. Ther. 30, 193207.
  • Torres G. E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W. D. and Caron M. G. (2003a) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 27312739.
  • Torres G. E., Gainetdinov R. R. and Caron M. G. (2003b) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 1325.
  • Trendelenburg U., Langeloh A. and Bönisch H. (1987) Mechanism of action of indirectly acting sympathomimetic amines. Blood Vessels 24, 261270.
  • Vaughan R. A., Huff R. A., Uhl G. R. and Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 1554115546.
  • Wall S. C., Gu H. and Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47, 544550.
  • Wang D., Deken S. L., Whitworth T. L. and Quick M. W. (2003) Syntaxin 1A inhibits GABA flux, efflux, and exchange mediated by the rat brain GABA transporter GAT1. Mol. Pharmacol. 64, 905913.
  • Widdas W. F. (1952) Inability of diffusion to account for placental glucose transfer in the sheep and consideration of the kinetics of a possible carrier transfer. J. Physiol. 118, 2339.
  • Willeit M., Sitte H. H., Thierry N. et al. (2008) Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology 33, 15031513.
  • Wolfel R. and Graefe K. H. (1992) Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter. Naunyn Schmiedebergs Arch. Pharmacol. 345, 129136.
  • Yamashita A., Singh S. K., Kawate T., Jin Y. and Gouaux E. (2005) Crystal structure of a bacterial homologue of Na+/Cl−-dependent neurotransmitter transporters. Nature 437, 215223.
  • Zaczek R., Culp S. and De S. E. (1991) Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. J. Pharmacol. Exp. Ther. 257, 830835.
  • Zhu C. B., Carneiro A. M., Dostmann W. R., Hewlett W. A. and Blakely R. D. (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J. Biol. Chem. 280, 1564915658.